ADGCX
Price
$28.58
Change
+$0.18 (+0.63%)
Updated
Oct 24 closing price
Net Assets
190.87M
VTSAX
Price
$162.44
Change
+$1.29 (+0.80%)
Updated
Oct 24 closing price
Net Assets
2.02T
Interact to see
Advertisement

ADGCX vs VTSAX

Header iconADGCX vs VTSAX Comparison
Open Charts ADGCX vs VTSAXBanner chart's image
AB Core Opportunities C
Price$28.58
Change+$0.18 (+0.63%)
VolumeN/A
Net Assets190.87M
Vanguard Total Stock Mkt Idx Adm
Price$162.44
Change+$1.29 (+0.80%)
VolumeN/A
Net Assets2.02T
ADGCX vs VTSAX Comparison Chart in %
View a ticker or compare two or three
VS
ADGCX vs. VTSAX commentary
Oct 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADGCX is a Buy and VTSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 2.02T vs. ADGCX (191M). VTSAX pays higher dividends than ADGCX: VTSAX (1.13) vs ADGCX (0.00). ADGCX was incepted earlier than VTSAX: ADGCX (26 years) vs VTSAX (25 years). ADGCX (1.92) is less costly to investors than VTSAX (0.04). ADGCX is a more actively managed with annual turnover of: 46.00 vs. VTSAX (2.00). ADGCX has a lower initial minimum investment than VTSAX: ADGCX (2500) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 15.95 vs. ADGCX (1.49). VTSAX return over 5 years is better than : 87.90 vs. ADGCX (6.29).
ADGCXVTSAXADGCX / VTSAX
Total Expense Ratio1.900.044,750%
Annual Report Gross Expense Ratio1.920.044,800%
Fund Existence26 years25 years-
Gain YTD15.62214.343109%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets191M2.02T0%
Annual Yield % from dividends0.001.13-
Returns for 1 year1.4915.959%
Returns for 3 years21.6472.0830%
Returns for 5 years6.2987.907%
Returns for 10 years3.77225.742%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NDRA5.000.04
+0.81%
ENDRA Life Sciences Inc
MANH194.850.17
+0.09%
Manhattan Associates
MQ4.72-0.03
-0.63%
Marqeta
MSB35.44-0.32
-0.89%
Mesabi Trust
ADVM4.07-0.11
-2.63%
Adverum Biotechnologies